Form 4 Tracker
Harlan S Robins

Chief Scientific Officer · 8 filings · Latest: Jul 21, 2026

Adaptive Biotechnologies Corp
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ADPT
Harlan S RobinsChief Scientific OfficerJul 21, 2026
Sale
$21.89492,400$10.8M812,058
ADPT
Harlan S RobinsChief Scientific OfficerJul 21, 2026
Option Exercise
$6.55284,800$1.9M1,304,458
ADPT
Harlan RobinsJul 21, 2026
Proposed Sale
$22.58492,400$11.1M
ADPT
Harlan S RobinsChief Scientific OfficerJul 2, 2026
Sale
$22.01386,240$8.5M1,019,658
ADPT
Harlan RobinsJul 2, 2026
Proposed Sale
$21.19386,240$8.2M
ADPT
Harlan S RobinsChief Scientific OfficerJun 16, 2026
Sale
$18.016,160$110.9K1,405,898
ADPT
Harlan S RobinsChief Scientific OfficerJun 15, 2026
Sale
$17.37100,000$1.7M1,412,058
ADPT
Harlan RobinsJun 16, 2026
Proposed Sale
$17.226,160$106.1K
ADPT
Harlan RobinsJun 15, 2026
Proposed Sale
$17.46100,000$1.7M
ADPT
Harlan S RobinsChief Scientific OfficerApr 8, 2026
Sale
$14.8510,000$148.5K1,512,058
ADPT
Harlan RobinsApr 8, 2026
Proposed Sale
$14.8410,000$148.4K
ADPT
ROBINS HARLAN SMar 11, 2026
Proposed Sale
$14.52470,266$6.8M
ADPT
Harlan S RobinsChief Scientific OfficerMar 11, 2026
Sale
$13.17470,266$6.2M1,522,058
ADPT
Harlan S RobinsChief Scientific OfficerMar 3, 2026
Sale
$16.5214,233$235.1K1,155,291
ADPT
Harlan S RobinsChief Scientific OfficerMar 2, 2026
Sale
$15.7210,000$157.2K1,169,524
ADPT
Harlan RobinsMar 3, 2026
Proposed Sale
$16.0814,233$228.9K
ADPT
Harlan RobinsMar 2, 2026
Proposed Sale
$16.1210,000$161.2K
ADPT
Harlan S RobinsChief Scientific OfficerFeb 3, 2026
Sale
$19.008,120$154.3K1,179,524
ADPT
Harlan S RobinsChief Scientific OfficerFeb 2, 2026
Sale
$18.6034,668$644.8K1,187,644
ADPT
Harlan RobinsFeb 3, 2026
Proposed Sale
$18.508,120$150.2K

Page 1 of 2

Next →